Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals

Journal of the American Society of Nephrology

Volumn 10, Issue 7, 1999, Pages 1542-1549

  Remuzzi, Giuseppe ^a   Zoja, Carla ^a   Gagliardini, Elena ^a   Corna, Daniela ^a   Abbate, Mauro ^a,b   Benigni, Ariela ^a  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DENDRITIC CELL; IMMUNOHISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY INTERSTITIUM; LEUKOCYTE; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE;

EID: 0033060074     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Remuzzi G, Ruggenenti P, Benigni A: Understanding the nature of renal disease progression. Kidney Int 51: 2-15, 1997
2. The Gisen Group: Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 349: 1857-1863, 1997
3. Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G, on behalf of the GISEN Group: Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int 53: 1209-1216, 1998
4. Wang Y, Chen J, Chen L, Tay Y-C, Rangan GK, Harris DCH: Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8: 1537-1545, 1997
5. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation. Kidney Int 53: 1608-1615, 1998
6. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, Ronco PM, Remuzzi G: Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 26: 934-941, 1995
7. Donadelli R, Zoja C, Benigni A, Bruzzi I, Abbate M, Balducci D, Zanchi C, Remuzzi G: ACE inhibition while reducing proteinuria also suppresses NF-KB activation and reduces renal MCP-1 in rats with remnant kidney [Abstract]. J Am Soc Nephrol 9: 453A, 1998
8. Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, Benatti L, Remuzzi G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 43: 354-358, 1993
9. MacCumber MW, Ross CA, Glaser BM, Snyder SH: Endothelin: Visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci USA 86: 7285-7289, 1989
10. Tang WW, Qi M, Warren JS, Van GY: Chemokine expression in experimental tubulointerstitial nephritis. J Immunol 159: 870-876, 1997
11. Zoja C, Liu X-H, Abbate M, Corna D, Schiffrin EL, Remuzzi G, Benigni A: Angiotensin II blockade limits tubular protein over-reabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy. Exp Nephrol 6: 121-131, 1998
12. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 612-619, 1985
13. Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A: Passive Heymann nephritis: Evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Nephrol 4: 213-221, 1996
14. Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G: The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: Evidence based on comparative studies with a receptor antagonist. Am J Kidney Dis 29: 254-264, 1997
15. Ots M, Mackenzie HS, Troy JL, Rennke HG, Brenner BM: Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. J Am Soc Nephrol 9: 224-230, 1998
16. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G: In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 9: 1213-1224, 1998
17. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392: 245-252, 1998
18. Olson JL, Hostetter TH, Rennke HG, Brenner BM, Venkatachalam MA: Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int 22: 112-126, 1982
19. Pfeffer JM, Pfeffer MA, Frohlich ED: Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med 78: 957-962, 1971
20. Read SM, Northcote DH: Minimization of variation in the response to different proteins of the Coomassie blue G dye-binding assay for protein. Anal Biochem 116: 53-64, 1981
21. Bonses RW, Tausski HA: The colorimetric determination of creatinine of the Jaffé reaction. J Biol Chem 158: 581, 1945
22. Demetris AJ, Murase N, Ye Q, Galvao FHF, Richert C, Saad R, Pham S, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE: Analysis of chronic rejection and obliterative arteriopathy. Am J Pathol 150: 563-578, 1997
23. Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G: Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-β in experimental mesangioproliferative glomerulonephritis. Am J Kidney Dis 31: 453-463, 1998
24. Brenner BM, Meyer TW, Hostetter TH: Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307: 652-659, 1982
25. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-394, 1990
26. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998
27. Eddy AA, McCulloch L, Adams J, Liu E: Interstitial nephritis induced by protein-overload proteinuria. Am J Pathol 135: 719-733, 1989
28. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 85: 541-549, 1990
29. Yoshioka T, Rennke HG, Salant DJ, Deen WM, Ichikawa I: Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: A study in early passive Heymann nephritis. Circ Res 61: 531-538, 1987
30. Nath KA, Hostetter MK, Hostetter TH: Pathophysiology of chronic tubulo-interstitial disease in rats: Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 76: 667-675, 1985
31. Kees-Folts D, Sadow JL, Schreiner GF: Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 45: 1697-1709, 1994
32. Lee KW, Nadeau K, Troy JL, Tilney NL, Brenner BM, Mackenzie HS: Cytokines and growth factor expression in remnant kidneys of 5/6 nephrectomized Munich-Wistar rats (5/6NPX) [Abstract]. J Am Soc Nephrol 1: 1858, 1996
33. Eugui EM, Mirkovich A, Allison AC: Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice. Scand J Immunol 33: 175-183, 1991
34. Danovitch GM: Mycophenolate mofetil in renal transplantation: Results from the U.S. randomized trials. Kidney Int 48[Suppl 52]: S93-S96, 1995
35. European Mycophenolate Mofetil Cooperative Study Group: Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345: 1321-1325, 1995
36. Azuma H, Binder J, Heemann U, Schmid C, Tullius SG, Tilney NL: Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts. Transplantation 59: 460-466, 1995
37. Heemann U, Azuma H, Hamar P, Schmid C, Tilney N, Philipp T: Mycophenolate mofetil inhibits lymphocyte binding and the upregulation of adhesion molecules in acute rejection of rat kidney allografts. Transplant Immunol 4: 64-67, 1996
38. Hagerty DT, Allen PM: Processing and presentation of self and foreign antigens by the renal proximal tubule. J Immunol 148: 2324-2330, 1992
39. Haverty TP, Kelly CJ, Hines WH, Amenta PS, Watanbe M, Harper RA, Kefalides NA, Neilson EG: Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J Cell Biol 107: 1359-1368, 1988
40. Haverty TP, Watanabe M, Neilson EG, Kelly CJ: Protective modulation of class II MHC gene expression in tubular epithelium by target antigen-specific antibodies. J Immunol 143: 1133-1141, 1989
41. Rubin-Kelley VE, Jevnikar AM: Antigen presentation by renal tubular epithelial cells. J Am Soc Nephrol 2: 13-26, 1991